• Distinct Mechanism of Gepotidacin Versus Fluoroquinolones in

  2026-07-17

  This article examines the structural and mechanistic basis for gepotidacin's inhibition of Staphylococcus aureus DNA gyrase, as described in Gibson et al. The study reveals how gepotidacin, unlike fluoroquinolones such as Moxifloxacin, induces single-stranded rather than double-stranded DNA breaks and binds in a mutually exclusive manner to the gyrase-DNA complex. These findings help inform the design of new antibiotics and underscore the value of established fluoroquinolones for comparative research.

• L-Glutathione Reduced in Redox Regulation: Protocols & Pitfa

  2026-07-17

  L-Glutathione Reduced is indispensable for probing cellular redox mechanisms and optimizing glutathione S-transferase workflows. This article demystifies experimental applications, troubleshooting, and stepwise protocols, with a focus on relevance to cancer metabolism and oxidative stress research.

• Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Ubiquitina

  2026-07-16

  The referenced study reveals that gramine, a natural indole alkaloid, suppresses triple-negative breast cancer (TNBC) by promoting ferroptosis through the CUL3–MTDH ubiquitination axis. These findings provide mechanistic insight into ferroptosis-based therapies and highlight new opportunities for targeted interventions in aggressive breast cancer subtypes.

• EdU Cell Proliferation Kit (TMB): S-Phase Detection & Eviden

  2026-07-16

  The EdU Cell Proliferation Kit (TMB) enables direct, sensitive quantification of S-phase DNA synthesis using 5-ethynyl-2'-deoxyuridine incorporation. This assay offers high specificity for cell proliferation measurement, providing a robust tool for genotoxicity and pharmacodynamic research in diverse cell models.

• AO/PI Staining Solution: Precision Cell Viability for Transl

  2026-07-15

  Explore how AO/PI Staining Solution, a dual fluorescent DNA dye reagent, revolutionizes accurate cell viability assays for translational and disease-model research. This article uncovers advanced protocol insights and connects cell discrimination technology to cutting-edge nephrology findings.

• Linoleic Acid (C18:2(9Z,12Z)) in Oxidative Stress Assays

  2026-07-15

  Linoleic Acid (C18:2(9Z,12Z)) from APExBIO is a powerful tool for modeling oxidative stress, membrane dynamics, and essential fatty acid deficiency in cell-based and animal assays. Recent translational research reveals novel signaling and metabolic roles that refine its application in redox biology, wound healing, and nutritional deficiency workflows.

• Linoleic Acid (C18:2(9Z,12Z)): Protocols and QC in Oxidative

  2026-07-14

  Linoleic Acid (C18:2(9Z,12Z); SKU C3108) is an established reagent for modeling oxidative stress, membrane fluidity, and essential fatty acid deficiency in cellular and animal workflows. It is best suited for assays where precise manipulation of lipid environment, redox balance, or barrier function is required and should not be used where water-soluble fatty acids are necessary or long-term solution stability is critical.

• Structure-Based Inhibitor Discovery Targeting SARS-CoV-2 NSP

  2026-07-14

  This study applies structure-based virtual screening and molecular dynamics to identify natural product inhibitors of SARS-CoV-2 NSP15, highlighting thymopentin and oleuropein as lead candidates. These findings advance antiviral drug discovery by targeting a nonstructural protein critical for viral immune evasion.

• AICAR: AMPK Activation and Metabolic Research Utility

  2026-07-13

  AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) is a potent, cell-permeable AMPK activator widely used in energy metabolism regulation studies. Its well-characterized mechanism enables targeted inflammation inhibition and metabolic disease research. Precise handling and protocol adherence are essential for reproducible results.

• Sildenafil Citrate: Proteoform-Specific Applications in Vasc

  2026-07-13

  Explore how Sildenafil Citrate, a leading cGMP-specific phosphodiesterase type 5 inhibitor, is advancing proteoform-specific and membrane-native vascular research. This article uniquely bridges cutting-edge proteomics with practical assay strategies for deeper insight into signaling complexity.

• EZ Cap™ Cre mRNA (m1Ψ): Precision Cre Recombinase mRNA for E

  2026-07-12

  EZ Cap™ Cre mRNA (m1Ψ) enables efficient, transient Cre recombinase expression with high mRNA stability and minimal immunogenicity, optimized for gene editing beyond the liver. Its innovative modifications and compatibility with advanced delivery systems make it a go-to choice for researchers targeting extrahepatic tissues.

• Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Ubiquitina

  2026-07-10

  The reference study uncovers a novel regulatory pathway by which Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) suppresses triple-negative breast cancer through CUL3-mediated ubiquitination of MTDH, inducing ferroptosis. This mechanistic advance highlights Gramine’s research utility in dissecting ferroptosis and ubiquitination in aggressive cancer models.

• Optimizing Cell Assays with G-1 (CAS 881639-98-1), a Selecti

  2026-07-09

  This scenario-driven article explores how G-1 (CAS 881639-98-1), a selective GPR30 agonist (SKU B5455), addresses real-world challenges in cell viability and signaling assays. Practical Q&A blocks highlight the compound's specificity, reproducibility, and performance advantages, guiding biomedical researchers to robust experimental outcomes.

• PDI Inhibition Enhances Panobinostat Efficacy in Multiple My

  2026-07-09

  Robinson et al. (2022) demonstrate that the protein disulfide isomerase (PDI) inhibitor LTI6426 substantially amplifies the antitumor activity of Panobinostat (LBH589) in preclinical models of multiple myeloma. This combination strategy enables effective dose reduction of Panobinostat, mitigating toxicity while activating key ER stress pathways, with implications for safer, more potent epigenetic therapies.

• NU7441 (KU-57788) DNA-PK Inhibitor: Optimizing Oncology Assa

  2026-07-08

  NU7441 (KU-57788) stands out in oncology and DNA repair research as a nanomolar-potency, highly selective DNA-PK inhibitor. This article delivers actionable workflow enhancements, advanced applications, and troubleshooting expertise to maximize reproducibility and sensitivity using APExBIO’s trusted compound.

450 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page